A new BMJ study offers the first population-based CTE prevalence estimate for NFL players, finding a minimum of 25% among those who died from 2016-2021.
A two-antibody click-chemistry strategy improves targeted chemotherapy delivery to resistant HER2- and EGFR-positive tumors, boosting tumor control in mice.
The Trump administration has been progressively shrinking AHRQ, the only federal agency focused on supporting research to improve the safety and quality of healthcare.
An OB/GYN, clinical geneticist and former health-system quality leader explains what testosterone can offer women today – and why the next chapter must be better research.
Following a parade of health insurance company earnings reports this summer, stocks are rising and costs appear to be under control — for now.
Family coverage often stops at the state line. For students far from home, the emergency room becomes the only reliable door — and the most expensive one.
New research suggests deep-sea vent metals powered early metabolism before enzymes existed, revealing how life may have begun making essential molecules on Earth.
The share of US kindergartners without both MMR doses has risen from 4.8 to 7.6 percent since 2019, and the shortfall is concentrated in schools county averages cannot see.
A new era in tuberculosis care has begun with the introduction of a highly affordable molecular test, priced at just $2.60. Global rollout is now underway.
The new movie “Novak Djokovic: The Wolf in Winter” profiled where the 39-year-old is currently in his tennis career, showing he’s still a threat to win the U.S. Open.